Literature DB >> 24061457

Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.

A Hemalatha1, T N Suresh, M L Harendra Kumar.   

Abstract

CONTEXT: Vimentin is a mesenchymal marker, known to express in some epithelial carcinomas. AIMS: 1. To find out the expression of vimentin in infiltrating ductal carcinoma of breast (not otherwise specified), 2. To find out the correlation between expression of vimentin and prognostic markers such as tumor size, tumor grade, lymph node status, proliferation index (measured by Ki 67), and Nottingham prognostic index (NPI).
MATERIALS AND METHODS: Study was done at Department of Pathology; 50 cases of infiltrating ductal carcinoma (NOS) were studied for tumor grade; immunohistochemistry was done using antibodies against vimentin and Ki 67. Percentages of positive cells were documented. An immunoscore was also calculated for vimentin. Vimentin expression was correlated with tumor size, lymph node status, Nottingham prognostic index, and Ki 67. STATISTICAL ANALYSIS USED: statistical correlation was done using Pearson's chi-square test. A P value less than 0.01 was considered significant.
RESULTS: Vimentin expression was seen in 18% of cases. Its expression correlated with high tumor grade and high growth fraction (P value < 0.01). It did not correlate with lymph node status, tumor size, and NPI.
CONCLUSIONS: Increased vimentin expression is associated with bad prognostic factors. Immunohistochemistry with vimentin may be helpful in knowing the prognosis in cases of infiltrating ductal carcinoma of breast (NOS).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24061457     DOI: 10.4103/0019-509X.118724

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  10 in total

1.  MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.

Authors:  Fei Ren; Lisha Wang; Xiaohan Shen; Xiuying Xiao; Zebing Liu; Ping Wei; Yiqin Wang; Peng Qi; Chen Shen; Weiqi Sheng; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

2.  Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer.

Authors:  Mohammed Elimam Ahamed Mohammed; Nuha Mohammed Elhassan
Journal:  J Int Med Res       Date:  2019-10-11       Impact factor: 1.671

3.  Expression of vimentin filaments in canine malignant mammary gland tumors: A simulation of clinicopathological features of human breast cancer.

Authors:  Sanaz Rismanchi; Orly Yadegar; Samad Muhammadnejad; Saeid Amanpour; Masoud Taghizadeh-Jahed; Ahad Muhammadnejad
Journal:  Biomed Rep       Date:  2014-07-08

4.  Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Despoina Myoteri; Dionysios Dellaportas; Panagis M Lykoudis; Alexandros Apostolopoulos; Athanasios Marinis; Adamantia Zizi-Sermpetzoglou
Journal:  Gastroenterol Res Pract       Date:  2017-03-22       Impact factor: 2.260

5.  BMP-2 Variants in Breast Epithelial to Mesenchymal Transition and Microcalcifications Origin.

Authors:  Manuel Scimeca; Raffaella Giocondo; Manuela Montanaro; Annarita Granaglia; Rita Bonfiglio; Virginia Tancredi; Alessandro Mauriello; Nicoletta Urbano; Orazio Schillaci; Elena Bonanno
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

6.  Immunohistochemical Expression of Vimentin in Invasive Breast Carcinoma and Its Correlation with Clinicopathological Parameters.

Authors:  Chaitnya D Khillare; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Maithili M Kulkarni; Bageshri P Gogate; Shivani Battin
Journal:  Niger Med J       Date:  2019 Jan-Feb

Review 7.  Prognostic Factors Involved in the Epithelial-Mesenchymal Transition Process in Colorectal Cancer Have a Preponderant Role in Oxidative Stress: A Systematic Review and Meta-Analysis.

Authors:  Eva Parisi; Anabel Sorolla; Robert Montal; Rita González-Resina; Anna Novell; Antonieta Salud; Maria Alba Sorolla
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

8.  Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231).

Authors:  Roya Naderi; Shiva Gholizadeh-Ghaleh Aziz; Amir Salar Haghigi-Asl
Journal:  Ann Med Surg (Lond)       Date:  2022-01-04

9.  Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix.

Authors:  Nazik Elmalaika O S Husain; Ali Yousif Babiker; Aqel S Albutti; Mohammed A Alsahli; Salah M Aly; Arshad H Rahmani
Journal:  Obstet Gynecol Int       Date:  2016-04-14

10.  Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan.

Authors:  Hina Sarwath; Devendra Bansal; Nazik Elmalaika Husain; Mahmoud Mohamed; Ali A Sultan; Shahinaz Bedri
Journal:  Infect Agent Cancer       Date:  2017-09-30       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.